{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:15:30Z","timestamp":1792883730549,"version":"4.5.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.fitote.2024.106185","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:34:42Z","timestamp":1723502082000},"page":"106185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Natural compounds combined with imatinib as promising antileukemic therapy: An updated review"],"prefix":"10.1016","volume":"178","author":[{"given":"Salvador Enrique","family":"Meneses-Sagrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Alondra","family":"Rasc\u00f3n-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Evarista","family":"Arellano-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanis","family":"Toledano-Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2024.106185_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022, CA","volume":"72","author":"Siegel","year":"2022","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.fitote.2024.106185_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-020-00170-6","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","volume":"9","author":"Dong","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0015","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: national cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.fitote.2024.106185_bb0020","series-title":"Leukemia","author":"Chennamadhavuni","year":"2023"},{"key":"10.1016\/j.fitote.2024.106185_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022, CA","volume":"72","author":"Miller","year":"2022","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.fitote.2024.106185_bb0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.fitote.2024.106185_bb0035","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.fitote.2024.106185_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-3-47","article-title":"First-line treatment for chronic myeloid leukemia: Dasatinib, nilotinib, or imatinib","volume":"3","author":"Wei","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.21380","article-title":"First-line therapy for chronic myeloid leukemia: past, present, and future","volume":"84","author":"Pavlovsky","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.fitote.2024.106185_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPH.0000000000002660","article-title":"Effect of Imatinib Mesylate on growth in pediatric chronic myeloid leukemia: a systematic review and Meta-analysis","volume":"45","author":"Gupta","year":"2023","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","article-title":"Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes","volume":"16","author":"Stagno","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.fitote.2024.106185_bb0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111451118","article-title":"Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance","volume":"118","author":"Lyczek","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.fitote.2024.106185_bb0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","article-title":"BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-frequency and clinical outcome","volume":"38","author":"Elias","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0070","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose Cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mrgentox.2016.12.002","article-title":"Assessment of the genotoxicity of the tyrosine kinase inhibitor imatinib mesylate in cultured fish and human cells","volume":"814","author":"Novak","year":"2017","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.fitote.2024.106185_bb0080","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jsps.2019.10.005","article-title":"Evaluation of oxidative stress responses in human circulating blood cells after imatinib mesylate treatment \u2013 implications to its mechanism of action","volume":"27","author":"Gajski","year":"2019","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.fitote.2024.106185_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrclinonc.2016.59","article-title":"Targeted therapy: generic imatinib-impact on frontline and salvage therapy for CML","volume":"13","author":"Gorkin","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5045\/br.2020.2020130","article-title":"Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib switch) study","volume":"55","author":"Gemelli","year":"2020","journal-title":"Blood Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0095","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1002\/cam4.2545","article-title":"Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States","volume":"8","author":"Abou Dalle","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jphs.2015.10.008","article-title":"Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cells","volume":"129","author":"Wei","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.fitote.2024.106185_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114351","article-title":"Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia","volume":"160","author":"Goel","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0571-x","article-title":"Targeting acute myeloid leukemia stem cell signaling by natural products","volume":"16","author":"Siveen","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.fitote.2024.106185_bb0120","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.fitote.2024.106185_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","article-title":"Natural Products in Cancer therapy: past, present and future","volume":"11","author":"Huang","year":"2021","journal-title":"Nat. Products Bioprospect."},{"key":"10.1016\/j.fitote.2024.106185_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100277","article-title":"The anticancer activity of carbazole alkaloids","volume":"355","author":"Song","year":"2022","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.fitote.2024.106185_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1574892815666201002162315","article-title":"Serafini, Terpenes with antitumor activity: a patent review, recent pat","volume":"15","author":"de Vasconcelos Cerqueira","year":"2020","journal-title":"Anticancer. Drug Discov."},{"key":"10.1016\/j.fitote.2024.106185_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094763","article-title":"Selected monocyclic monoterpenes and their derivatives as effective anticancer therapeutic agents","volume":"22","author":"Zieli\u0144ska-B\u0142ajet","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0145","series-title":"Med. Plants","first-page":"333","article-title":"Therapeutic and medicinal uses of terpenes","author":"Cox-Georgian","year":"2019"},{"key":"10.1016\/j.fitote.2024.106185_bb0150","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.3390\/ijms22115710","article-title":"Biochemistry of terpenes and recent advances in plant protection","volume":"22","author":"Ninkuu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120728","article-title":"Pharmacological and biological effects of alpha-bisabolol: an updated review of the molecular mechanisms","volume":"304","author":"Ramazani","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0046674","article-title":"\u03b1-Bisabolol is an effective Proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib","volume":"7","author":"Bonifacio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fitote.2024.106185_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-9-45","article-title":"Pro-apoptotic activity of \u03b1-bisabolol in preclinical models of primary human acute leukemia cells","volume":"9","author":"Cavalieri","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0175","series-title":"Multiple Biological Effects of an Iridoid Glucoside, Catalpol and its Underlying Molecular Mechanisms","author":"Bhattamisra","year":"2020"},{"key":"10.1016\/j.fitote.2024.106185_bb0180","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ptr.5272","article-title":"The hydrolysed products of iridoid glycosides can enhance imatinib mesylate-induced apoptosis in human myeloid leukaemia cells","volume":"29","author":"Kim","year":"2015","journal-title":"Phyther. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0185","article-title":"Oridonin: a review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0190","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4161\/cbt.21460","article-title":"Oridonin in combination with imatinib exerts synergetic anti-leukemia effects in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN\/mTOR signaling pathway","volume":"13","author":"Guo","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.fitote.2024.106185_bb0195","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tox.2011.04.004","article-title":"16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that involve in cancer cell apoptosis","volume":"285","author":"Lin","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.fitote.2024.106185_bb0200","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.3390\/molecules25173958","article-title":"16-Hydroxycleroda-3,13-Dien-15,16-Olide induces apoptosis in human bladder Cancer cells through cell cycle arrest, mitochondria ROS overproduction, and inactivation of EGFR-related Signalling pathways","volume":"25","author":"Chen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104633","article-title":"Cryptotanshinone: a review of its pharmacology activities and molecular mechanisms","volume":"145","author":"Wu","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.fitote.2024.106185_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fddsv.2022.815017","article-title":"A Mini-review of the anticancer properties of Cryptotanshinone: a Quinoid Diterpene extracted from the root of Salvia miotiorrhiza Bunge","volume":"2","author":"Naziri","year":"2022","journal-title":"Front. Drug Discov."},{"key":"10.1016\/j.fitote.2024.106185_bb0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/10428194.2014.928934","article-title":"Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells","volume":"56","author":"Ge","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.fitote.2024.106185_bb0220","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.3390\/ijms20122926","article-title":"Costunolide\u2014a bioactive Sesquiterpene lactone with diverse therapeutic potential","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0225","doi-asserted-by":"crossref","first-page":"10888","DOI":"10.3390\/ijms160510888","article-title":"Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone","volume":"16","author":"Lin","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0230","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ptr.6106","article-title":"Costunolide promotes imatinib-induced apoptosis in chronic myeloid leukemia cells via the Bcr\/Abl\u2013Stat5 pathway","volume":"32","author":"Cai","year":"2018","journal-title":"Phyther. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0235","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2017.08.123","article-title":"Glycyrrhizic acid: a promising carrier material for anticancer therapy","volume":"95","author":"Su","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0240","doi-asserted-by":"crossref","first-page":"997","DOI":"10.21873\/anticanres.11409","article-title":"Treatment of hematological malignancies with glycyrrhizic acid","volume":"37","author":"Hostetler","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2006.04.006","article-title":"Pharmacological properties of the ubiquitous natural product betulin","volume":"29","author":"Alakurtti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.883857","article-title":"Anti-inflammatory activities of Betulinic acid: a review","volume":"13","author":"Oliveira-Costa","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0043-123472","article-title":"New pharmacological opportunities for Betulinic acid","volume":"84","author":"R\u00edos","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0260","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11101-019-09623-1","article-title":"Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential","volume":"18","author":"Hordyjewska","year":"2019","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.fitote.2024.106185_bb0265","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm1095-1046","article-title":"Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis","volume":"1","author":"Pisha","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0669-8","article-title":"Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78 article","volume":"9","author":"Cai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fitote.2024.106185_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111990","article-title":"Betulinic acid in the treatment of tumour diseases: application and research progress","volume":"142","author":"Jiang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.14298","article-title":"Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase\u2212independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation","volume":"1467","author":"Lu","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0285","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1517\/13543784.2012.727395","article-title":"Terpenoids: natural products for cancer therapy","volume":"21","author":"Huang","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.fitote.2024.106185_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom14020200","article-title":"Terpenoid-mediated targeting of STAT3 signaling in cancer: an overview of preclinical studies","volume":"14","author":"Khan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0295","first-page":"323","article-title":"Antileukemic properties of sesquiterpene lactones: a systematic review. Anticancer agents","volume":"18","author":"Silva-Castro","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.fitote.2024.106185_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27154791","article-title":"Advances of natural abietane, labdane and cloredane diterpene as anti-cancer agents: sources and mechanism of action","volume":"27","author":"Acquaviva","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27238263","article-title":"Lupane triterpene derivatives improve antiproliferative effect on leukemia cells trough apoptosis induction","volume":"27","author":"Valencia-Chan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0310","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/cmdc.202100038","article-title":"Natural and semisynthetic pentacyclic triterpenes for chronic myeloid leukemia therapy: reality, challenges and perspectives","volume":"16","author":"Barreto-Viana","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.fitote.2024.106185_bb0315","article-title":"Alkaloids as potential antivirals. A comprehensive review","volume":"13","author":"Faisal","year":"2023","journal-title":"Nat. Products Bioprospect."},{"key":"10.1016\/j.fitote.2024.106185_bb0320","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11101-018-9575-z","article-title":"Phytochemicals and their effective role in the treatment of diabetes mellitus: a short review","volume":"17","author":"Teoh","year":"2018","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.fitote.2024.106185_bb0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s40200-021-00943-8","article-title":"Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus","volume":"21","author":"Singh","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.fitote.2024.106185_bb0330","first-page":"1","article-title":"Role of medicinal plants in the management of diabetes mellitus: a review","volume":"9","author":"Bindu","year":"2019","journal-title":"3 Biotech."},{"key":"10.1016\/j.fitote.2024.106185_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.fitote.2024.106185_bb0340","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00204-022-03418-8","article-title":"Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts","volume":"97","author":"Wu","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fitote.2024.106185_bb0345","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.leu.2404115","article-title":"High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia","volume":"20","author":"Rea","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.fitote.2024.106185_bb0350","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phyther. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0355","series-title":"Adv. Mol. Toxicol","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-812522-9.00006-3","article-title":"Metabolic activation and toxicities of bis-Benzylisoquinoline alkaloids","author":"Tian","year":"2017"},{"key":"10.1016\/j.fitote.2024.106185_bb0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2005.05.023","article-title":"Berbamine: a novel inhibitor of bcr\/abl fusion gene with potent anti-leukemia activity","volume":"30","author":"Xu","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0365","doi-asserted-by":"crossref","first-page":"75050","DOI":"10.18632\/oncotarget.20504","article-title":"Activation of CaMKII\u03b3 potentiates T-cell acute lymphoblastic leukemia leukemogenesis via phosphorylating FOXO3a","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.fitote.2024.106185_bb0370","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2012-06-434894","article-title":"CaMKII \u03b3, a critical regulator of CML stem\/progenitor cells, is a target of the natural product berbamine","volume":"120","author":"Gu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fitote.2024.106185_bb0375","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-2002-32896","article-title":"Inhibition of telomerase activity and bcl-2 expression in Berbamine-induced apoptosis in HL-60 cells","volume":"68","author":"Ji","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0380","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/ar.20924","article-title":"The antiproliferation effect of berbamine on K562 resistant cells by inhibiting NF-\u03baB pathway","volume":"292","author":"Wei","year":"2009","journal-title":"Anat. Rec."},{"key":"10.1016\/j.fitote.2024.106185_bb0385","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/aps.2009.19","article-title":"Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo","volume":"30","author":"Wei","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fitote.2024.106185_bb0390","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00029330-200705010-00012","article-title":"Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway","volume":"120","author":"Zhao","year":"2007","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.fitote.2024.106185_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9005804","article-title":"Synergistic lethality effects of Apatinib and Homoharringtonine in acute myeloid leukemia","volume":"2022","author":"Shi","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0400","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21037\/atm-22-1459","article-title":"Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms","volume":"10","author":"Yuan","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biocel.2004.04.007","article-title":"Mcl-1","volume":"37","author":"Michels","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0410","first-page":"113","article-title":"Homoharringtonine promotes BCR-ABL degradation through the p62-mediated autophagy pathway","volume":"43","author":"Li","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.fitote.2024.106185_bb0415","series-title":"Stud. Nat. Prod. Chem","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-444-63930-1.00010-7","article-title":"Chemistry, Bioactivity, and the Structure-Activity Relationship of Cephalotaxine-Type Alkaloids From Cephalotaxus sp","author":"Chang","year":"2017"},{"key":"10.1016\/j.fitote.2024.106185_bb0420","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1016\/j.clml.2021.06.002","article-title":"Efficacy and safety of Homoharringtonine for the treatment of acute myeloid leukemia: a meta-analysis","volume":"21","author":"Mi","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.fitote.2024.106185_bb0425","first-page":"3233","article-title":"Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX","volume":"20","author":"Wu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.fitote.2024.106185_bb0430","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cancers14040885","article-title":"Cannabidiol (CBD) in Cancer management","volume":"14","author":"O\u2019Brien","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fitote.2024.106185_bb0435","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.3390\/cancers12113203","article-title":"Cannabidiol (CBD) as a promising anti-Cancer drug","volume":"12","author":"Seltzer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fitote.2024.106185_bb0440","first-page":"817","article-title":"Mechanisms of Cannabidiol (CBD) in Cancer treatment: a review","volume":"11","author":"Heider","year":"2022","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.fitote.2024.106185_bb0445","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/cas.15257","article-title":"The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib","volume":"113","author":"Maggi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jfbc.13986","article-title":"An updated review on pharmacological properties of neferine\u2014a bisbenzylisoquinoline alkaloid from Nelumbo nucifera","volume":"45","author":"Bharathi Priya","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.fitote.2024.106185_bb0455","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lfs.2018.02.032","article-title":"Pharmacological benefits of neferine - a comprehensive review","volume":"199","author":"Marthandam Asokan","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0460","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/jcb.25937","article-title":"Neferine potentiates the antitumor effect of cisplatin in human lung adenocarcinoma cells via a mitochondria-mediated apoptosis pathway","volume":"118","author":"Sivalingam","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.fitote.2024.106185_bb0465","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/10428194.2010.550075","article-title":"Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells","volume":"52","author":"Qin","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.fitote.2024.106185_bb0470","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/1750-3841.14484","article-title":"Neferine in the Lotus Plumule potentiates the antitumor effect of Imatinib in primary chronic myeloid leukemia cells in vitro","volume":"84","author":"Zhang","year":"2019","journal-title":"J. Food Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113682","article-title":"Matrine: a review of its pharmacology, pharmacokinetics, toxicity, clinical application and preparation researches","volume":"269","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.977374","article-title":"Research progress on the pharmacological effects of matrine","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.fitote.2024.106185_bb0485","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejmech.2018.10.037","article-title":"Research advances on anticancer activities of matrine and its derivatives: an updated overview","volume":"161","author":"Rashid","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106185_bb0490","first-page":"1","article-title":"Matrine: a promising natural product with various pharmacological activities","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0495","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/13880200600714152","article-title":"Enhancement of imatinib-induced apoptosis by matrine in bcr\/abl-positive leukemia K562 cells","volume":"44","author":"Liu","year":"2006","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules28073149","article-title":"Papaverine: a miraculous alkaloid from opium and its multimedicinal application","volume":"28","author":"Ashrafi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0505","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01888-19","article-title":"Repurposing Papaverine as an antiviral agent against influenza viruses and paramyxoviruses","volume":"94","author":"Aggarwal","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.fitote.2024.106185_bb0510","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jphs.2020.07.008","article-title":"Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury","volume":"144","author":"Guan","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells11213385","article-title":"The biological relevance of Papaverine in Cancer cells","volume":"11","author":"Gomes","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.fitote.2024.106185_bb0520","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s43440-020-00196-x","article-title":"Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia","volume":"73","author":"Parcha","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.fitote.2024.106185_bb0525","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0973-7847.194047","article-title":"Anticancer alkaloids from trees: development into drugs","volume":"10","author":"Isah","year":"2016","journal-title":"Phcog. Rev."},{"issue":"172472","key":"10.1016\/j.fitote.2024.106185_bb0530","first-page":"1","article-title":"Alkaloids for cancer prevention and therapy: current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0535","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1074\/jbc.M211093200","article-title":"P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation","volume":"12","author":"Yag\u00fce","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2024.106185_bb0540","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/OTT.S191621","article-title":"Mechanis of drug resistance in acute myeloid leukemia","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.fitote.2024.106185_bb0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/CAD.0b013e32835a0fbd","article-title":"Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells","volume":"24","author":"Oh","year":"2013","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.fitote.2024.106185_bb0550","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/13880200500303734","article-title":"Alterations in tyrosine protein phosphorylation induced by matrine in leukemia cells","volume":"43","author":"Liu","year":"2005","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14143300","article-title":"Mechanism of resistance and implications for treatment strategies in chronic myeloid leukaemia","volume":"14","author":"Poudel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.fitote.2024.106185_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.719694","article-title":"Update and new insights on future cancer drug candidates from plant-based alkaloids","volume":"12","author":"Tilaoui","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.fitote.2024.106185_bb0565","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/14656566.9.6.1029","article-title":"Homoharringtonine for treatment of chronic myelogenous leukemia","volume":"9","author":"Quintas-Cardama","year":"2008","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0570","first-page":"1","article-title":"The role of mitophagy in regulating cell death","volume":"6617256","author":"Li","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.fitote.2024.106185_bb0575","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.5740\/jaoacint.19-0133","article-title":"Natural polyphenols: chemical classification, definition of classes, subcategories, and structures","volume":"102","author":"Singla","year":"2019","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.fitote.2024.106185_bb0580","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/medicines5030093","article-title":"Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview","volume":"5","author":"Tungmunnithum","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.fitote.2024.106185_bb0585","series-title":"Postharvest Physiol. Biochem. Fruits Veg","first-page":"253","article-title":"Phenolic compounds","author":"de la Rosa","year":"2019"},{"key":"10.1016\/j.fitote.2024.106185_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031186","article-title":"A concise profile of Gallic acid\u2014from its natural sources through biological properties and chemical methods of determination","volume":"28","author":"Wianowska","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112576","article-title":"Gallic acid for cancer therapy: molecular mechanisms and boosting efficacy by nanoscopical delivery","volume":"157","author":"Ashrafizadeh","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fitote.2024.106185_bb0600","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.tiv.2011.12.018","article-title":"Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR\/ABL kinase and NF-\u03baB inactivation","volume":"26","author":"Chandramohan Reddy","year":"2012","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.fitote.2024.106185_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.845871","article-title":"Potential therapeutic implications of Caffeic acid in Cancer signaling: past, present, and future","volume":"13","author":"Alam","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105759","article-title":"Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: new hope in the fight against cancer","volume":"171","author":"Mirzaei","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22041644","article-title":"Caffeic acid enhances the anti-leukemic effect of imatinib on chronic myeloid leukemia cells and triggers apoptosis in cells sensitive and resistant to imatinib","volume":"22","author":"Feriotto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315004","article-title":"A central contribution of TG2 activity to the Antiproliferative and pro-apoptotic effects of Caffeic acid in K562 cells of human chronic myeloid leukemia","volume":"23","author":"Feriotto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines6030091","article-title":"Resveratrol: a double-edged sword in health benefits","volume":"6","author":"Salehi","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.fitote.2024.106185_bb0630","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.biopha.2018.11.075","article-title":"Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases","volume":"109","author":"Pannu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0635","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fitote.2024.106185_bb0640","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/0008-5472.CAN-09-3537","article-title":"Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62\/SQSTM1 expression and AMPK activation","volume":"70","author":"Puissant","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0645","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3892\/ol.2014.2014","article-title":"Resveratrol inhibits the phosphatidylinositide 3-kinase\/protein kinase B\/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line","volume":"7","author":"Sui","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.fitote.2024.106185_bb0650","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","article-title":"Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol","volume":"22","author":"Puissant","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.fitote.2024.106185_bb0655","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.fitote.2024.106185_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153647","article-title":"Honokiol: a review of its pharmacological potential and therapeutic insights","volume":"90","author":"Rauf","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fitote.2024.106185_bb0665","first-page":"481","article-title":"Honokiol: a naturally occurring lignan with pleiotropic bioactivities","volume":"19","author":"Chen","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.fitote.2024.106185_bb0670","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2019.04.004","article-title":"Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets","volume":"144","author":"Banik","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0675","first-page":"1","article-title":"Honokiol: a review of its anticancer potential and mechanisms","volume":"12","author":"Ong","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fitote.2024.106185_bb0680","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/15376511003758831","article-title":"Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells","volume":"20","author":"Wang","year":"2010","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.fitote.2024.106185_bb0685","first-page":"472","article-title":"Curcumin and its derivatives: a review of their biological activities","volume":"11","author":"Oglah","year":"2020","journal-title":"Syst. Rev. Pharm."},{"key":"10.1016\/j.fitote.2024.106185_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.07.015","article-title":"Curcumin as tyrosine kinase inhibitor in cancer treatment","volume":"181","author":"Golonko","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106185_bb0695","doi-asserted-by":"crossref","first-page":"21918","DOI":"10.18632\/oncotarget.4204","article-title":"Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21","volume":"6","author":"Taverna","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.fitote.2024.106185_bb0700","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/mol.106.026575","article-title":"C-Abl kinase regulates curcumin-induced cell death through activation of c-Jun N-terminal kinase","volume":"71","author":"Kamath","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0705","article-title":"Curcumin decreases viability and inhibits proliferation of Imatinib-sensitive and Imatinib-resistant chronic myeloid leukemia cell lines","volume":"13","author":"Bilajac","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.fitote.2024.106185_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2015.05.003","article-title":"Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia","volume":"65","author":"Guo","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-20179-6","article-title":"Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth","volume":"8","author":"Larasati","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fitote.2024.106185_bb0720","first-page":"5224","article-title":"In vitro effect of curcumin in combination with chemotherapy drugs in Ph+ acute lymphoblastic leukemia cells","volume":"17","author":"Santana-Bejarano","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.fitote.2024.106185_bb0725","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1615\/JEnvironPatholToxicolOncol.2014010913","article-title":"Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6","volume":"33","author":"Sarkar","year":"2014","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.fitote.2024.106185_bb0730","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1080\/13880209.2016.1216131","article-title":"Therapeutic potential of naringin: an overview","volume":"54","author":"Chen","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.639840","article-title":"A systematic review of the preventive and therapeutic effects of Naringin against human malignancies","volume":"12","author":"Ghanbari-Movahed","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0740","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.53730\/ijhs.v6nS3.7888","article-title":"Evaluation of the combined effect of naringin and imatinib in Philadelphia positive chronic myeloid leukemia","volume":"6","author":"Gudimetla","year":"2022","journal-title":"Int. J. Health Sci. (Qassim)."},{"key":"10.1016\/j.fitote.2024.106185_bb0745","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/clpt.2011.102","article-title":"Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia","volume":"90","author":"Yamakawa","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fitote.2024.106185_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111808","article-title":"A comprehensive review on chemotherapeutic potential of galangin","volume":"141","author":"Rampogu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0755","first-page":"331","article-title":"Galangin, as a potential anticancer agent","volume":"32","author":"Singh","year":"2022","journal-title":"Rev. Bras"},{"key":"10.1016\/j.fitote.2024.106185_bb0760","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.biopha.2018.09.154","article-title":"Chemopreventive mechanisms of galangin against hepatocellular carcinoma: a review","volume":"109","author":"Fang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0765","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.canlet.2008.02.025","article-title":"Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells","volume":"265","author":"Tolomeo","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.fitote.2024.106185_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jbcpp-2019-0191","article-title":"Tangeretin: a mechanistic review of its pharmacological and therapeutic effects","volume":"31","author":"Ashrafizadeh","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2021.100010","article-title":"Incipient citrus polymethoxylated flavone Tangeretin as anticancer drug candidate: mechanistic insights, limitations and possible solutions","volume":"3","author":"Boye","year":"2021","journal-title":"Adv. Cancer Biol. - Metastasis."},{"key":"10.1016\/j.fitote.2024.106185_bb0780","doi-asserted-by":"crossref","first-page":"178","DOI":"10.14715\/cmb\/2021.67.2.28","article-title":"Antimetastatic effects of Citrus-derived bioactive ingredients: mechanistic insights","volume":"67","author":"Farooqi","year":"2021","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.fitote.2024.106185_bb0785","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/mnfr.200900186","article-title":"The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562","volume":"54","author":"Lust","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpain.2023.1114428","article-title":"Luteolin: a promising natural agent in management of pain in chronic conditions","volume":"4","author":"Ntalouka","year":"2023","journal-title":"Front. Pain Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108612","article-title":"Luteolin, a flavonoid, as an anticancer agent: a review","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2024.106185_bb0800","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CEJ.0000000000000128","article-title":"Molecular targets of luteolin in cancer","volume":"25","author":"Tuorkey","year":"2016","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.fitote.2024.106185_bb0805","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ptr.7044","article-title":"Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated","volume":"35","author":"Ganai","year":"2021","journal-title":"Phyther. Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0810","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4274\/balkanmedj.galenos.2018.2017.1244","article-title":"Cytotoxic effects of some flavonoids and imatinib on the K562 chronic myeloid leukemia cell line: data analysis using the combination index method","volume":"36","author":"Dan\u0131\u015fman Kal\u0131ndemirta\u015f","year":"2019","journal-title":"Balkan Medizinhist. J."},{"key":"10.1016\/j.fitote.2024.106185_bb0815","first-page":"359","article-title":"Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR\/ABL positive K562 cells","volume":"26","author":"Kamyabi","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.fitote.2024.106185_bb0820","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mc.22540","article-title":"Oroxylin a reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12\/CXCR7 axis in bone marrow microenvironment","volume":"56","author":"Li","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.fitote.2024.106185_bb0825","first-page":"1517","article-title":"Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combinig with conventional chemotherapeutic agents","volume":"9","author":"Kikuchi","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.fitote.2024.106185_bb0830","first-page":"S4","article-title":"Natural and synthetic flavonoids: structure activity relationship and chemotherapeutic potential for the treatment of leukemia","volume":"29","author":"Menezes","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.fitote.2024.106185_bb0835","first-page":"200","article-title":"Extraction of phenolic compounds: a review","volume":"4","author":"Alara","year":"2021","journal-title":"CRFS"},{"key":"10.1016\/j.fitote.2024.106185_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/foods11213323","article-title":"Dietary phenolic compounds as anticancer natural drugs: recent update on molecular mechanism and critical trials","volume":"11","author":"Bakrim","year":"2022","journal-title":"Foods"},{"issue":"221","key":"10.1016\/j.fitote.2024.106185_bb0845","first-page":"1","article-title":"Therapeutic potential of plant phenolic acids in the treatment of cancer","volume":"10","author":"Abotaleb","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0850","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2174\/138161208785294654","article-title":"Targeting cyclooxigenase-2 in hematological malignancies: rationale and promise","volume":"14","author":"Bernard","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.fitote.2024.106185_bb0855","first-page":"39","article-title":"The effect of caffeic acid phenethyl ester on cell cycle control gene expressions in breast cancer cells","volume":"10","author":"Balc","year":"2021","journal-title":"Mol. Biol. Res. Commun."},{"issue":"113128","key":"10.1016\/j.fitote.2024.106185_bb0860","first-page":"1","article-title":"Stilbenes: Source plants, chemistry, biosynthesis, pharmacology, application and problems related to their clinica aplication-A comprehensive review","volume":"197","author":"Teka","year":"2022"},{"key":"10.1016\/j.fitote.2024.106185_bb0865","first-page":"1","article-title":"Role of natural stilbenes in the prevention of cancer","volume":"3128951","author":"Sirerol","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2709","key":"10.1016\/j.fitote.2024.106185_bb0870","first-page":"1","article-title":"The anti-leukemic activity of natural compounds","volume":"26","author":"Cotoraci","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106185_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071686","article-title":"Naringin and naringenin: their mechanism of action and the potential anticancer activities","volume":"10","author":"Stabrauskiene","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.fitote.2024.106185_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01480545.2015.1039647","article-title":"Anti-genotoxic effect of narangin against bleomycin-induced genomic damage in human lymphocytes in vitro","author":"Yilmaz","year":"2015","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.fitote.2024.106185_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-149","article-title":"Protective effect of quercetin against oxidative stress caused by dimethoate in human peripheral blood lymphocytes","volume":"10","author":"Gargouri","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.fitote.2024.106185_bb0890","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jpp\/rgab013","article-title":"Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancer: a comparative overview","volume":"73","author":"Alhamad","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106185_bb0895","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ctim.2016.06.009","article-title":"Successful treatment of c-kit-positive metastatic adenoid cystic carcinoma (ACC) with a combination of curcumin plus imatinib: a case report","volume":"27","author":"Demiray","year":"2016","journal-title":"Complement. Ther. Med."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2400368X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2400368X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:27:01Z","timestamp":1726514821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X2400368X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":179,"alternative-id":["S0367326X2400368X"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106185","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural compounds combined with imatinib as promising antileukemic therapy: An updated review","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106185"}}